查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1932153

醫用塑膠射出成型成型製程市場（按機器類型、材料類型、製程技術、最終用戶和應用分類）—全球預測，2026-2032年

Medical Plastic Injection Molding Process Market by Machine Type, Material Type, Process Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫用塑膠射出成型製程市場規模將達到 198.4 億美元，到 2026 年將成長至 213.4 億美元，到 2032 年將達到 344.5 億美元，年複合成長率為 8.20%。

主要市場統計數據
基準年 2025 198.4億美元
預計年份：2026年 213.4億美元
預測年份：2032年 344.5億美元
複合年成長率 (%) 8.20%

深入了解醫用塑膠射出成型的現狀，將力學、材料科學和監管要求連結起來，以支持策略決策。

執行摘要簡要概述了醫用塑膠射出成型的現狀，重點闡述了精密工程、嚴格法規和材料科學的融合如何支撐現代醫療設備的製造。本報告旨在幫助決策者清楚了解正在重塑診斷設備、藥物輸送系統、植入和手術器械生產的技術、供應鏈和監管因素。報告指出，射出成型不僅是一種製造程序，更是一種戰略要素，它能夠實現產品差異化、確保設備安全並控制成本，最終實現商業化。

機器精度的提高、材料的創新以及數位化品管技術的進步正在重塑醫療器材模俱生產的工作流程和供應商生態系統。

本節檢驗了正在重塑醫用塑膠射出成型在臨床應用領域的構思、檢驗和大量生產方式的變革性轉變。機械控制系統的進步，包括更嚴格的封閉回路型製程控制和伺服驅動，提高了微創器械所需微結構的重複性。同時，混合動力平台和先進的多成分注塑成型技術拓展了設計自由度，並實現了包覆成型和雙色注塑成型工藝，從而在單一製造過程中將軟性彈性體密封件與剛性結構基材整合在一起。這些技術變革減少了組裝步驟，並提高了介面完整性至關重要的器械的密封性。

進口關稅結構的變化如何促進策略採購、本地化和生命週期成本最佳化，以保障供應連續性和製造業經濟效益

2025年美國關稅政策引發了一系列成本和供應鏈調整，這些調整波及籌資策略和區域製造地。關稅調整增加了某些進口注塑機、備件和聚合物原料的總到岸成本，促使製造商重新評估集中式大量生產和分散式近岸外包方案之間的平衡。為此，採購團隊正在評估替代供應商，協商長期合約以穩定投入成本風險，並進行情境規劃，考慮關鍵模具和二次加工的本地化。

針對特定領域的製造和材料要求，使機械設計、聚合物選擇和製程技術與最終用戶和應用需求保持一致。

細分市場分析揭示了機器類型、材料、製程技術、最終用戶和應用的多樣性如何影響製造策略和商業性定位。就機器架構而言，水平平台以多種配置形式存在，包括全電動、混合動力水平和液壓式。混合動力臥式擴展了包覆成型和雙色注塑成型能力，而垂直機器支援嵌件成型，適用於嵌件方向和固定要求嚴格的場合。這些差異會影響資本投資計畫、無塵室面積和維護方案，其中全電動系統可提供更嚴格的環境控制，而液壓系統則仍能滿足更高的噸位需求。

醫療模俱生產、模具製造和檢驗活動位置中的區域競爭和營運考量

醫療塑膠射出射出成型的區域趨勢受管理體制、供應商密度和本地製造能力的影響。在美洲，成熟的醫療技術叢集接近性大型醫院系統和契約製造製造商，從而能夠加快認證週期，並促進設計和生產團隊之間的緊密合作。該地區受益於完善的物流走廊，這些走廊支持各種規模的生產，從批量生產的一次性部件到專業植入製造，並有助於臨床試驗用品的供應和快速補貨。

透過精密加工能力、整合服務、材料合作和成熟的供應鏈韌性實現競爭優勢

該領域製造商和供應商之間的競爭格局主要取決於他們在工程深度、合規生產和整合服務方面的差異化優勢。領先的供應商透過投資精密成型能力（包括微組分和多成分成型）、完善的驗證通訊協定和在線連續檢測技術來脫穎而出。那些建構了從可製造性設計協助和原型製作到全規模射出成型和二次加工等全方位服務組合的公司，更有能力贏得需要單一來源供應和高效認證的OEM夥伴關係。

實用經營團隊藍圖：協調機器選擇、材料協作、供應鏈韌性和勞動力能力，以加速合規製造

產業領導者應優先考慮整合技術投資、供應商夥伴關係和監管準備的策略，以加速產品上市，同時控制總成本和合規風險。首先，應根據產品複雜程度，選擇性地投資最合適的機械平台。對於高精度加工和無塵室整合，優先考慮全電動和混合動力系統；而在不可避免地需要進行大噸位加工的情況下，則保留液壓設備。將機械升級與流程分析技術 (PAT) 和在線連續測試相結合，以確保即時獲得品質回饋並縮短認證週期。

採用嚴謹的混合研究途徑，結合實地觀察、專家訪談和技術審查，得出檢驗且具有實際應用價值的研究結果。

本報告的研究結果基於混合方法調查方法，旨在確保其深度和相關性，以滿足製造商、原始設備製造商 (OEM) 和監管機構等相關人員的需求。主要研究包括對醫療設備供應鏈中的製造工程師、品質經理和採購專業人員進行結構化訪談，以了解營運實務和投資決策背後的邏輯。除訪談外，還訪問了生產設施和模具車間，對機器配置、無塵室整合和檢驗程序進行了現場觀察。次要研究包括對與材料、驗證和滅菌方法相關的技術文獻、行業標準和監管指南進行系統性回顧。

將資本投資、供應商選擇和管治結合的綜合策略重點，旨在加速醫用塑膠零件的合規商業化進程。

總之，醫用塑膠射出成型產業正處於一個轉折點，精密機械、尖端材料和工藝創新正在融合，以滿足日益嚴格的臨床和監管要求。製造商若能根據產品複雜性策略性地配置機械投資，與材料供應商緊密合作以確保共同開發和合格，並實現品管數位化，將在產品上市時間和可製造性方面獲得顯著優勢。此外，區域因素和關稅趨勢也在影響製造商的決策，例如製造地的位置、供應鏈關係的建構以及何時投資前置作業時間和模組化自動化以縮短交貨週期。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按機器類型分類的醫用塑膠射出成型成型製程市場

  • 水平機
    • 全電動臥式機
    • 混合式臥式機
    • 液壓臥式機
  • 混合電子機械
    • 包覆成型機
    • 雙色注塑機
  • 立式機械
    • 通用立式工具機
    • 嵌件成型機

9. 依材料類型分類的醫用塑膠射出成型成型製程市場

  • 彈性體
    • 矽橡膠
    • 熱可塑性橡膠
  • 熱塑性塑膠
    • 聚碳酸酯
    • 聚乙烯
    • 聚丙烯
  • 熱固性樹脂
    • 環氧樹脂
    • 酚醛樹脂
    • 矽樹脂

10. 依製程技術分類的醫用塑膠射出成型成型製程市場

  • 傳統射出成型
    • 高壓成型
    • 低壓成型
  • 嵌件成型
    • 陶瓷嵌件成型
    • 金屬嵌件成型
  • 微型射出成型
    • 奈米精密成型
  • 多成分射出成型
    • 三色注塑成型
    • 雙色注塑成型
  • 包覆成型
    • 模內裝飾
    • 插入式包覆成型

第11章 依最終用戶分類的醫用塑膠射出成型成型製程市場

  • 診所
    • 門診部
    • 專科診所
  • 診斷實驗室
    • 臨床檢查室
    • 研究所
  • 醫院
    • 公立醫院
    • 私立醫院
  • 製藥公司
    • 定製配方製造商
    • 學名藥生產商

第12章 醫用塑膠射出成型製程市場（依應用領域分類）

  • 診斷設備
    • 影像組件
    • 檢測套組
  • 藥物輸送裝置
    • 點滴幫浦
    • 吸入器
    • 注射器
  • 植入
    • 心血管植入
    • 整形外科植入
  • 手術器械
    • 鉗子
    • 女性
    • 剪刀

13. 各地區醫用塑膠射出成型成型製程市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫用塑膠射出成型製程市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫用塑膠射出成型成型製程市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國醫用塑膠射出成型成型製程市場

第17章：中國醫用塑膠射出成型製程市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accumold, Inc.
  • Anil Plastics and Enterprises Pvt. Ltd.
  • Gerresheimer AG
  • HTI Plastics, Inc.
  • Jabil Inc.
  • Medbio, Inc.
  • Nemera SA
  • Nolato MediTech AB
  • Phillips-Medisize Corporation
  • Proto Labs, Inc.
  • Rutland Plastics, Inc.
  • SMC Ltd.
  • Spectrum Plastics Group, Inc.
  • Stevanato Group SpA
  • TE Connectivity Ltd.
  • Tessy Plastics, Inc.
  • The Plastek Group, Inc.
  • Viant Medical, Inc.
  • Vidhata Plastics Pvt. Ltd.
  • West Pharmaceutical Services, Inc.
Product Code: MRR-7B550E008FB3

The Medical Plastic Injection Molding Process Market was valued at USD 19.84 billion in 2025 and is projected to grow to USD 21.34 billion in 2026, with a CAGR of 8.20%, reaching USD 34.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 19.84 billion
Estimated Year [2026] USD 21.34 billion
Forecast Year [2032] USD 34.45 billion
CAGR (%) 8.20%

A precise orientation to the medical plastic injection molding landscape that links machine architecture, material science, and regulatory imperatives for strategic decision-making

The executive summary opens with a concise orientation to the current state of medical plastic injection molding, emphasizing the convergence of precision engineering, regulatory rigor, and materials science that underpins device manufacturing today. This introduction frames the report's intent: to equip decision-makers with a clear understanding of the technological, supply chain, and regulatory forces reshaping production of diagnostic devices, drug delivery systems, implants, and surgical instruments. It situates injection molding not merely as a production step but as a strategic enabler of product differentiation, device safety, and cost-to-commercialization dynamics.

Throughout the report, special attention is paid to how machine architecture, material selection, and process technology interact to determine manufacturability, cycle efficiency, and regulatory compliance. The analysis considers horizontal, hybrid electric, and vertical injection platforms and the implications of all-electric, hybrid, and hydraulic configurations for part complexity and cleanroom integration. It also outlines how materials ranging from elastomers and thermoplastics to thermosets demand distinctive processing regimes and downstream validation steps. By establishing this foundation, the introduction prepares stakeholders to assess trade-offs between tool investment, production flexibility, and long-term quality assurance imperatives.

Ultimately, the introduction sets expectations for the remainder of the executive summary: pragmatic insight grounded in manufacturing realities, actionable segmentation analysis, regional competitiveness perspectives, and recommendations intended to accelerate secure, scalable production of medical-grade plastic components.

How advances in machine precision, materials innovation, and digital quality controls are reshaping production workflows and supplier ecosystems in medical molding

This section examines the transformative shifts that are redefining how medical plastic injection molding is conceived, validated, and scaled for clinical use. Advancements in machine control systems, including tighter closed-loop process regulation and servo-driven actuation, are enabling higher repeatability for microscale features required by minimally invasive devices. Concurrently, hybrid electric platforms and sophisticated multi-component molding techniques are expanding design freedom, enabling overmolding and two-shot processes that integrate soft elastomeric seals with rigid structural substrates in a single production sequence. These technological shifts are reducing assembly steps and improving hermeticity in devices where interface integrity is critical.

Material innovation is another pivotal driver of change. The evolution of thermoplastic formulations, high-purity silicones, and specialized thermoset resins is improving biocompatibility and sterilization resilience, which in turn affects choice of molding parameters and post-processing validation protocols. Process-level innovation, such as micro injection and precision molding, is enabling consistent manufacture of sub-millimeter geometries with rigorous surface finish requirements. As a result, manufacturers are increasingly integrating in-line inspection and process analytical technologies to detect deviations in real time, thereby reducing scrap rates and improving first-pass yield.

Finally, regulatory expectations and payer-driven demands for cost-effective manufacturing are prompting a shift toward digitalized documentation, enhanced supplier qualification, and modular cleanroom designs that accommodate both high-volume production and low-volume, high-complexity batches. These combined forces are driving a reorientation of capital allocation, skill development, and supplier ecosystems across the industry.

How changes in import duty structures have prompted strategic sourcing, localization, and lifecycle cost optimization to protect supply continuity and manufacturing economics

The U.S. tariff environment in 2025 introduced a set of cost and supply-chain recalibrations that ripple across sourcing strategies and regional manufacturing footprints. Tariff adjustments have elevated the total landed cost of certain imported molding machines, spare parts, and polymer feedstocks, which has led manufacturers to reassess the balance between centralized high-volume manufacturing and distributed nearshoring options. In response, procurement teams have undertaken scenario planning to evaluate alternative suppliers, negotiate longer-term agreements to stabilize input cost exposure, and explore localization of critical tooling and secondary operations.

Where tariffs have increased capital equipment costs, organizations have examined lifecycle cost models more rigorously, prioritizing machines with higher energy efficiency and lower total cost of ownership to offset upfront duty impacts. Simultaneously, materials managers have accelerated qualification programs for substitute polymers that meet biocompatibility and sterilization criteria but are sourced from tariff-favored jurisdictions. These efforts have required tighter coordination between regulatory and sourcing functions to ensure that material substitutions do not introduce compliance risk or delay product approvals.

Operationally, some manufacturers have strategically rebalanced production across multiple facilities to reduce customs exposure and to preserve lead times for clinically critical components. Others have invested in modular automation and flexible manufacturing cells that allow rapid scaling without incurring incremental tariff liabilities on bulk imports. The overarching effect has been a pragmatic recalibration of capital deployment, supplier risk management, and product qualification timelines to maintain supply continuity and control unit economics in a tariff-influenced environment.

Segment-specific manufacturing and materials imperatives that align machine architecture, polymer selection, and process technology to end-user and application demands

Segmentation analysis reveals how variation across machine types, materials, process technologies, end users, and applications informs both manufacturing strategy and commercial positioning. Within machine architecture, horizontal platforms proliferate in configurations that include all-electric, hybrid horizontal, and hydraulic variants, while hybrid electric options expand capabilities for overmolding and two-shot molding; vertical machines support insert molding and are preferred where insert orientation and insert retention are critical. These distinctions shape capital planning, cleanroom footprint, and maintenance regimes, with all-electric systems offering tighter environmental control and hydraulic systems remaining relevant for high-tonnage requirements.

Material segmentation shows that elastomers-divided between silicone and thermoplastic elastomers-serve sealing and soft-touch functions, while thermoplastics such as polycarbonate, polyethylene, and polypropylene are commonly selected for structural components and parts requiring autoclavability or chemical resistance. Thermosets including epoxy, phenolic, and silicone resins are applied where dimensional stability under heat and solvent exposure is paramount. The interplay between material choice and process technology is significant: conventional injection molding splits into high- and low-pressure approaches, insert molding can accommodate ceramic and metal inserts, micro injection supports nano-precision geometries, multi-component techniques enable two- and three-shot assemblies, and overmolding strategies incorporate in-mold decorating and insert overmolding to streamline assembly and improve part aesthetics and performance.

End-user segmentation highlights differing priorities: clinics and specialty ambulatory centers emphasize cost and sterility, diagnostic laboratories prioritize precision and disposable workflows, hospitals demand scale, traceability, and compliance, and pharmaceutical companies-both custom formulators and generic manufacturers-require validated supply chains and material traceability. Application segmentation connects these needs with product design: diagnostic devices balance optical clarity for imaging components and functional surfaces for test kits; drug delivery systems must integrate pumps, inhalers, or syringes with high fluid compatibility; implants require cardiovascular or orthopedic-grade biocompatible materials and dimensional tolerance control; and surgical instruments demand repeatable sharpness and sterilization-resistant finishes. Together, these segmentation lenses provide a structured way to align manufacturing investments with end-market requirements and regulatory checkpoints.

Regional competitive dynamics and operational considerations that determine where to locate production, tool-making, and validation activities for medical molding

Regional dynamics in the medical plastic injection molding landscape are shaped by regulatory regimes, supplier density, and local manufacturing capabilities. In the Americas, established medtech clusters provide proximity to large hospital systems and contract manufacturers, enabling rapid qualification cycles and close collaboration between design and production teams. This geography supports a range of production scales, from high-volume single-use components to specialized implant manufacturing, and benefits from established logistics corridors that facilitate clinical trial supply and rapid replenishment.

In Europe, Middle East & Africa, manufacturers navigate a heterogeneous regulatory and reimbursement landscape that encourages high standards for materials traceability and environmental compliance. This region hosts advanced precision-molding capabilities and numerous established tooling houses with expertise in multi-component systems and insert molding, though cross-border regulatory variation necessitates detailed compliance roadmaps for companies planning pan-regional distribution. Emerging markets within the region present cost-competitive opportunities for secondary operations and localized assembly.

Asia-Pacific combines deep supply-base scale with accelerated innovation in process automation and materials science. Proximity to polymer production and competitive manufacturing costs make the region an attractive source for both standard and customized components. At the same time, manufacturers operating in Asia-Pacific are increasingly investing in quality systems, cleanroom certifications, and local regulatory expertise to meet the expectations of global OEMs. Across regions, firms are balancing cost, quality, and lead-time criteria to configure regional footprints that support both global device launches and localized production for specific markets.

Competitive differentiation shaped by precision capabilities, integrated service offerings, material co-development, and demonstrable supply resilience

Competitive dynamics among manufacturers and suppliers in the sector are being driven by differential strengths in engineering depth, regulatory-compliant production, and integrated service offerings. Leading suppliers are distinguishing themselves through investments in precision molding capabilities, including micro and multi-component molding, along with robust validation protocols and in-line inspection technologies. Firms that have developed comprehensive service portfolios-from design for manufacturability support and prototyping to full-scale injection molding and secondary operations-are better positioned to capture OEM partnerships where single-source supply and streamlined qualification are preferred.

Strategic collaboration between material producers and molders is increasingly common, enabling faster material qualification cycles and co-development of custom resin formulations that meet device-specific performance and sterilization criteria. Companies that offer validated biocompatible material options, combined with documented sterilization compatibility, reduce time and complexity for device manufacturers seeking regulatory clearance. Moreover, suppliers emphasizing digitalization-such as integrated production data platforms, SPC-based process controls, and traceability systems-are delivering measurable operational advantages by lowering defect rates and supporting robust audit trails.

Finally, the market rewards organizations that maintain demonstrable supply resilience, including diversified sourcing, localized spare-part inventories, and rapid-response maintenance teams. Service-level differentiation, evidenced through contract guarantees and qualification support, remains a critical competitive lever in supplier selection processes.

Actionable roadmap for executives to align machine selection, material co-development, supply resilience, and workforce capability to accelerate compliant manufacturing

Industry leaders should prioritize a cohesive strategy that aligns technology investments, supplier partnerships, and regulatory readiness to accelerate product introductions while controlling total cost and compliance risk. First, invest selectively in machine platforms that offer the greatest alignment with product complexity-favoring all-electric and hybrid-electric systems for precision and cleanroom integration while retaining hydraulic assets where high-tonnage operations are unavoidable. Pair machine upgrades with process analytical technology and in-line inspection to ensure immediate quality feedback and to shorten qualification cycles.

Second, formalize closer collaboration with material suppliers to co-develop and pre-qualify polymers and elastomers for target sterilization regimes, biocompatibility requirements, and end-use mechanical specifications. By coordinating upstream material validation with downstream molding trials, companies can reduce rework and de-risk regulatory submissions. Third, enhance supply-chain resilience by qualifying alternate sources for critical machines, tooling, and polymers, and by implementing modular production cells that allow rapid redeployment across facilities. Consider nearshoring strategic operations when tariff exposure or lead-time constraints threaten clinical program timelines.

Finally, strengthen cross-functional governance structures that unite engineering, quality, and procurement around defined qualification gates and change-control protocols. Invest in workforce development to build specialist skills in micro molding, multi-component set-ups, and process validation. Together, these actions form a pragmatic roadmap for leaders aiming to deliver reliable, scalable, and compliant manufacturing for medical-grade plastic components.

A rigorous mixed-methods research approach combining field observations, expert interviews, and technical review to produce verifiable, operationally relevant insights

The report's findings are grounded in a mixed-methods research methodology designed to ensure both depth and relevance for manufacturers, OEMs, and regulatory stakeholders. Primary research included structured interviews with manufacturing engineers, quality leaders, and procurement specialists across the medical device supply chain to capture operational realities and investment rationales. These interviews were complemented by visits to production facilities and tooling houses to observe machine configurations, cleanroom integration, and inspection routines in situ. Secondary research encompassed a systematic review of technical literature, industry standards, and regulatory guidance relevant to materials, validation, and sterilization practices.

Data synthesis involved triangulating qualitative insights with observed production practices to generate robust segmentation logic and to validate the practical implications of material and process choices. Key themes were stress-tested through advisory sessions with subject-matter experts in micro molding and polymer chemistry to ensure technical accuracy. Throughout the research process, validation steps included cross-referencing interview findings with documented supplier capabilities, tooling specifications, and publicly available regulatory decisions to minimize bias and to ensure that conclusions reflect field-proven approaches.

The methodology emphasizes traceability and reproducibility: every major insight is linked to source interviews or observed practices, and recommendations are presented with the assumptions and constraints that informed them. This approach ensures that the analysis is actionable, technically grounded, and suitable for operational planning.

Synthesis of strategic priorities that connect capital investment, supplier qualification, and governance to accelerate compliant commercialization of medical plastic components

In conclusion, the medical plastic injection molding sector is at an inflection point where precision machinery, advanced materials, and process innovation converge to meet increasingly stringent clinical and regulatory demands. Manufacturers that strategically align machine investments with product complexity, that partner closely with material suppliers for co-development and qualification, and that digitalize quality controls will gain a measurable advantage in time-to-market and manufacturability. Moreover, regional and tariff-driven dynamics are influencing decisions about where to locate manufacturing, how to structure supply relationships, and when to invest in nearshoring or modular automation to protect lead times.

The synthesis offered here is intended to help executives and technical leaders prioritize initiatives that reduce risk and improve manufacturing predictability. By integrating targeted capital investment, enhanced supplier qualification, and cross-functional governance, organizations can better navigate the trade-offs between cost, speed, and regulatory assurance. The result is a practical framework that supports faster clinical translation, consistent device performance, and defensible supplier selection practices-enabling companies to focus on innovation while maintaining the operational discipline required for patient safety and regulatory compliance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Plastic Injection Molding Process Market, by Machine Type

  • 8.1. Horizontal Machines
    • 8.1.1. All-Electric Horizontal Machines
    • 8.1.2. Hybrid Horizontal Machines
    • 8.1.3. Hydraulic Horizontal Machines
  • 8.2. Hybrid Electric Machines
    • 8.2.1. Overmolding Machines
    • 8.2.2. Two-Shot Molding Machines
  • 8.3. Vertical Machines
    • 8.3.1. General Vertical Machines
    • 8.3.2. Insert Molding Machines

9. Medical Plastic Injection Molding Process Market, by Material Type

  • 9.1. Elastomers
    • 9.1.1. Silicone Elastomers
    • 9.1.2. Thermoplastic Elastomers
  • 9.2. Thermoplastics
    • 9.2.1. Polycarbonate
    • 9.2.2. Polyethylene
    • 9.2.3. Polypropylene
  • 9.3. Thermosets
    • 9.3.1. Epoxy Resins
    • 9.3.2. Phenolic Resins
    • 9.3.3. Silicone Resins

10. Medical Plastic Injection Molding Process Market, by Process Technology

  • 10.1. Conventional Injection
    • 10.1.1. High-Pressure Molding
    • 10.1.2. Low-Pressure Molding
  • 10.2. Insert Molding
    • 10.2.1. Ceramic Insert Molding
    • 10.2.2. Metal Insert Molding
  • 10.3. Micro Injection
    • 10.3.1. Nano Precision Molding
  • 10.4. Multi-Component Injection
    • 10.4.1. Three-Shot Molding
    • 10.4.2. Two-Shot Molding
  • 10.5. Overmolding
    • 10.5.1. In-Mold Decorating
    • 10.5.2. Insert Overmolding

11. Medical Plastic Injection Molding Process Market, by End User

  • 11.1. Clinics
    • 11.1.1. Ambulatory Clinics
    • 11.1.2. Specialty Clinics
  • 11.2. Diagnostic Laboratories
    • 11.2.1. Clinical Laboratories
    • 11.2.2. Research Laboratories
  • 11.3. Hospitals
    • 11.3.1. Government Hospitals
    • 11.3.2. Private Hospitals
  • 11.4. Pharmaceutical Companies
    • 11.4.1. Custom Formulators
    • 11.4.2. Generic Manufacturers

12. Medical Plastic Injection Molding Process Market, by Application

  • 12.1. Diagnostic Devices
    • 12.1.1. Imaging Components
    • 12.1.2. Test Kits
  • 12.2. Drug Delivery Devices
    • 12.2.1. Infusion Pumps
    • 12.2.2. Inhalers
    • 12.2.3. Syringes
  • 12.3. Implants
    • 12.3.1. Cardiovascular Implants
    • 12.3.2. Orthopedic Implants
  • 12.4. Surgical Instruments
    • 12.4.1. Forceps
    • 12.4.2. Scalpels
    • 12.4.3. Scissors

13. Medical Plastic Injection Molding Process Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Plastic Injection Molding Process Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Plastic Injection Molding Process Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Plastic Injection Molding Process Market

17. China Medical Plastic Injection Molding Process Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Accumold, Inc.
  • 18.6. Anil Plastics and Enterprises Pvt. Ltd.
  • 18.7. Gerresheimer AG
  • 18.8. HTI Plastics, Inc.
  • 18.9. Jabil Inc.
  • 18.10. Medbio, Inc.
  • 18.11. Nemera S.A.
  • 18.12. Nolato MediTech AB
  • 18.13. Phillips-Medisize Corporation
  • 18.14. Proto Labs, Inc.
  • 18.15. Rutland Plastics, Inc.
  • 18.16. SMC Ltd.
  • 18.17. Spectrum Plastics Group, Inc.
  • 18.18. Stevanato Group S.p.A.
  • 18.19. TE Connectivity Ltd.
  • 18.20. Tessy Plastics, Inc.
  • 18.21. The Plastek Group, Inc.
  • 18.22. Viant Medical, Inc.
  • 18.23. Vidhata Plastics Pvt. Ltd.
  • 18.24. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MACHINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PROCESS TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HORIZONTAL MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HORIZONTAL MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HORIZONTAL MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HORIZONTAL MACHINES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ALL-ELECTRIC HORIZONTAL MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ALL-ELECTRIC HORIZONTAL MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ALL-ELECTRIC HORIZONTAL MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYBRID HORIZONTAL MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYBRID HORIZONTAL MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYBRID HORIZONTAL MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYDRAULIC HORIZONTAL MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYDRAULIC HORIZONTAL MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYDRAULIC HORIZONTAL MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYBRID ELECTRIC MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYBRID ELECTRIC MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYBRID ELECTRIC MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYBRID ELECTRIC MACHINES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY OVERMOLDING MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY OVERMOLDING MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY OVERMOLDING MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY TWO-SHOT MOLDING MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY TWO-SHOT MOLDING MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY TWO-SHOT MOLDING MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY VERTICAL MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY VERTICAL MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY VERTICAL MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY VERTICAL MACHINES, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY GENERAL VERTICAL MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY GENERAL VERTICAL MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY GENERAL VERTICAL MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT MOLDING MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT MOLDING MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT MOLDING MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ELASTOMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ELASTOMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ELASTOMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ELASTOMERS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SILICONE ELASTOMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SILICONE ELASTOMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SILICONE ELASTOMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOPLASTIC ELASTOMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOPLASTIC ELASTOMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOPLASTIC ELASTOMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOSETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOSETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOSETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOSETS, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY EPOXY RESINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY EPOXY RESINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY EPOXY RESINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PHENOLIC RESINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PHENOLIC RESINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PHENOLIC RESINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SILICONE RESINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SILICONE RESINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SILICONE RESINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CONVENTIONAL INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CONVENTIONAL INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CONVENTIONAL INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CONVENTIONAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HIGH-PRESSURE MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HIGH-PRESSURE MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HIGH-PRESSURE MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY LOW-PRESSURE MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY LOW-PRESSURE MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY LOW-PRESSURE MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT MOLDING, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CERAMIC INSERT MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CERAMIC INSERT MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CERAMIC INSERT MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY METAL INSERT MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY METAL INSERT MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY METAL INSERT MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MICRO INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MICRO INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MICRO INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MICRO INJECTION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY NANO PRECISION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY NANO PRECISION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY NANO PRECISION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MULTI-COMPONENT INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MULTI-COMPONENT INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MULTI-COMPONENT INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MULTI-COMPONENT INJECTION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THREE-SHOT MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THREE-SHOT MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THREE-SHOT MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY TWO-SHOT MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY TWO-SHOT MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY TWO-SHOT MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY OVERMOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY OVERMOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY OVERMOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY OVERMOLDING, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IN-MOLD DECORATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IN-MOLD DECORATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IN-MOLD DECORATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT OVERMOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT OVERMOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT OVERMOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY AMBULATORY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY AMBULATORY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CUSTOM FORMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CUSTOM FORMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CUSTOM FORMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY GENERIC MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY GENERIC MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IMAGING COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IMAGING COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IMAGING COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DRUG DELIVERY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DRUG DELIVERY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INHALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INHALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY FORCEPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY FORCEPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY FORCEPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SCALPELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SCALPELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SCALPELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SCISSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SCISSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SCISSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 210. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 211. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HORIZONTAL MACHINES, 2018-2032 (USD MILLION)
  • TABLE 213. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYBRID ELECTRIC MACHINES, 2018-2032 (USD MILLION)
  • TABLE 214. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY VERTICAL MACHINES, 2018-2032 (USD MILLION)
  • TABLE 215. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ELASTOMERS, 2018-2032 (USD MILLION)
  • TABLE 217. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 218. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOSETS, 2018-2032 (USD MILLION)
  • TABLE 219. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CONVENTIONAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 221. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT MOLDING, 2018-2032 (USD MILLION)
  • TABLE 222. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MICRO INJECTION, 2018-2032 (USD MILLION)
  • TABLE 223. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MULTI-COMPONENT INJECTION, 2018-2032 (USD MILLION)
  • TABLE 224. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY OVERMOLDING, 2018-2032 (USD MILLION)
  • TABLE 225. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 227. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 228. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 229. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 230. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 232. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 234. AMERICAS MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HORIZONTAL MACHINES, 2018-2032 (USD MILLION)
  • TABLE 238. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HYBRID ELECTRIC MACHINES, 2018-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY VERTICAL MACHINES, 2018-2032 (USD MILLION)
  • TABLE 240. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY ELASTOMERS, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY THERMOSETS, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CONVENTIONAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 246. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY INSERT MOLDING, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MICRO INJECTION, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY MULTI-COMPONENT INJECTION, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY OVERMOLDING, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. NORTH AMERICA MEDICAL PLASTIC INJECTION MOLDING PROCESS MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 259. NORTH A